Autori: Ellebaek Eva
| Naslov | Efficacy of combined BRAF-MEK inhibitor second-line therapy in patients with non-resectable or metastatic BRAFV600-positive melanoma after prior immunotherapy: A retrospective EUMelaReg multicenter study (Article) |
| Autori | Ellebaek Eva ... Dujovic Branko ... (broj koautora 49) |
| Info | EJC SKIN CANCER, (2026), vol. 4 br. , str. - |
| Projekat | Novartis AG, Basel, Switzerland |
| Ispravka | ISI/Web of Science Članak |
